Medifast (MED) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Imperial Capital Downgrades Medifast (MED) to In-Line
November 7, 2014 6:45 AM ESTImperial Capital downgraded Medifast (NYSE: MED) from Outperform to In-Line with a price target of $32.00 (from $34.00).
Analyst Mitchell Pinheiro comments, "Our price target is about 3% below the recent share price. Our In-Line rating is based on our lower earnings forecast for 2015 which incorporates more subdued growth in the Take Shape For Life segment, the expectation for a flat... More



